BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:44 PM
 | 
Sep 11, 2012
 |  BC Extra  |  Company News

Regorafenib receives Priority Review in Japan for colorectal cancer

Bayer AG (Xetra:BAYN) said the Japanese Ministry of Health, Labor and Welfare (MHLW) granted Priority Review for an NDA for regorafenib to treat unresectable, advanced or recurrent colorectal cancer. The application, which was submitted...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >